Market revenue in 2022 | USD 41.1 million |
Market revenue in 2030 | USD 72.6 million |
Growth rate | 7.4% (CAGR from 2022 to 2030) |
Largest segment | Blood culture media |
Fastest growing segment | Assay Kits & Reagents |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Instruments, Blood Culture Media, Assay Kits & Reagents, Software |
Key market players worldwide | BD, BioMerieux SA, Thermo Fisher Scientific Inc, Danaher Corp, Roche Holding AG ADR, Luminex, Koninklijke Philips NV, Bruker Corp, Cepheid, Immunexpress |
Blood culture media was the largest segment with a revenue share of 38.93% in 2022. Horizon Databook has segmented the France sepsis diagnostics market based on instruments, blood culture media, assay kits & reagents, software covering the revenue growth of each sub-segment from 2018 to 2030.
According to the European Sepsis Alliance, sepsis is estimated to be responsible for nearly 57,000 deaths in France each year. This high mortality rate highlights the critical need for enhanced sepsis diagnosis and treatment protocols in France.
Improving early detection and intervention can potentially save lives and reduce the overall economic impact of sepsis on the healthcare system. According to an article published by the National Institutes of Health in August 2023, sepsis imposes a significant burden on European health systems and society.
These figures highlight the substantial economic impact of sepsis on healthcare systems, emphasizing the urgent need for effective diagnostic and treatment strategies to manage this life threatening condition & mitigate its financial strain.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account